Abstract

Current Opinion in Infectious Diseases was launched in 1988. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of infectious diseases is divided into 11 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue. Section Editors Marc J. StruelensMarc J. StruelensMarc Struelens completed his medical degree at the Université Libre de Bruxelles (ULB), Belgium in 1980. After obtaining a Diploma of Tropical Medicine at Prince Léopold Institute of Tropical Medicine in Antwerp, he worked for 3 years as Research Associate at the International Centre for Diarrhoeal Diseases Research, Bangladesh. He returned to Brussels in 1984 to become Board certified in Clinical Pathology at ULB- Erasme Hospital and completed his masters in Hospital Epidemiology and Infection Control in 1987. He obtained a PhD on the molecular epidemiology of nosocomial infections in 1993 and developed and directed the hospital epidemiology and infection control unit. He was appointed Associate Professor then full Professor of Medical Microbiology and Chair of the Microbiology-Immunology Board at the Faculty of Medicine of the ULB, Associate Head of Clinic then Director of the Department of Microbiology, Erasme Hospital, Director of the national reference laboratory for MRSA and Head of the Infectious Diseases Epidemiology Unit, School of Public Health, ULB (until 2009). In 2010, he joined the European Centre for Disease Prevention and Control as Senior Expert, Scientific Advice Unit, Antimicrobial Resistance and Healthcare-Associated Infections. He has published over 230 peer-reviewed articles and 25 book chapters and served as editor or editorial advisor for international journals including Current Opinion in Infectious Diseases, Clinical Epidemiology, Future Microbiology, Microbial Drug Resistance, International Journal of Antimicrobial Agents, Clinical Microbiology and Infection, Infection, Journal of Medical Microbiology, Reviews in Medical Microbiology, Infection Genetics and Evolution and Journal of Microbiological Methods. He has served as Scientific Officer and President for the European Society for Clinical Microbiology and Infectious Diseases, and chaired the European Study Group on Epidemiological Markers, the Belgian Infection Control Society and the Belgian Infectious Disease Advisory Board. He has been member of national and international advisory boards, including WHO and European Commission expert consultations and participated in EU-supported research networks in the fields of microbiology, hospital infection and antimicrobial resistance. He has been awarded distinctions, such as the Belgian Society for Clinical Microbiology and Infectious Diseases Award and elected Fellow of the Society for Healthcare Epidemiology of America and member of the European Academy of Clinical Microbiology and Infectious Diseases. José G. MontoyaJosé G. MontoyaDr Montoya is originally from Cali, Colombia and completed his medical degree with honors at the Universidad del Valle. He trained in Internal Medicine at Tulane University in New Orleans. Following his residency, he completed his fellowship in Infectious Diseases at Stanford University in Palo Alto under the mentorship of Dr Jack S. Remington. He is currently Associate Professor of Medicine and founder and co-director of the Immunocompromised Host Service at Stanford University Medical Center. He is also the Director of the National Reference Laboratory for the Diagnosis and Management of Toxoplasmosis in the United States at the Palo Alto Medical Foundation in Palo Alto, California.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call